Bayer Aktiengesellschaft holds the cleaner structural position, with growth as the main driver and profitability adding further support. Pfizer still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (BAYN.DE: DAX 40, PFE: Russell 1000).
The result is anchored in growth, but profitability also reinforces the same direction. The overall score gap is 11 points in favour of Bayer Aktiengesellschaft.
Both operate in: Drug Manufacturers - General
This comparison is based on industry proximity, not on functional trajectory similarity. BAYN.DE and PFE share the same industry classification.
For a similarity-based comparison, see how Bayer Aktiengesellschaft and Pfizer each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Bayer Aktiengesellschaft looks stronger on relative valuation, while the broader price setup remains mixed.
Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.
Where BAYN.DE and PFE each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
Earnings growth is one contributing factor within the growth lead.
Pfizer Inc. still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.
Growth is the clearest driver of the lead, with profitability adding further support — though stability still provides a real counterweight.
Break down the BAYN.DE vs PFE comparison across all dimensions with the full interactive tool.
Explore how BAYN.DE and PFE each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.